Michael Stanchina is a Respiratory physician affiliated with Brown University. OpenAlex indexes 32 publications with 2,592 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1407 S County Trl
East Greenwich, RI 028181620
Telephone
401-886-7910Provider last certified this registry record 3 Jun 2026.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202511 payments$19,352openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202514 payments$11,371openpaymentsdata.cms.gov ↗
- Regeneron Healthcare Solutions, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
64.8%Corticosteroid39.1%Trelegy Ellipta45%Breo Ellipta18%Budesonide-Formoterol Fumarate10%Fluticasone Propionate8%Breztri Aerosphere7%Symbicort7%Qvar Redihaler2%Dulera2%Arnuity Ellipta1%Part D<11 patientsbeta2-Adrenergic Agonist13.9%Albuterol Sulfate Hfa74%Ventolin Hfa27%Part D≥109 patients+ 4 more classes in this area
Nervous system
17.4%gamma-Aminobutyric Acid A Receptor Positive Modulator5.9%Zolpidem Tartrate100%Part D≥32 patientsBenzodiazepine1.8%Clonazepam62%Lorazepam38%Part D<11 patients+ 10 more classes in this area
Metabolism & gastrointestinal
8.1%Corticosteroid7.4%Prednisone100%Part D≥117 patientsProton pump inhibitor0.7%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Rare Presentation of Cystic Lung Disease: Lymphoid Interstitial Pneumonia and Pulmonary Hypertension as Presenting Feature of Sjögren's Syndrome
American Journal of Respiratory and Critical Care Medicine
2025 - The impact of different CPAP delivery approaches on nightly adherence and discontinuation rate in patients with obstructive sleep apnea
Journal of Clinical Sleep Medicine
2022 - Is Hyperinflation from Chronic Obstructive Pulmonary Disease “Protective” of Upper Airway Collapse in Obstructive Sleep Apnea?
Annals of the American Thoracic Society
2016
Similar KOLs
Other experts from the same institution or the same specialty.
James Klinger, MD
Brown University
Sharon Rounds, MD
Brown University
William Corrao, MD
Brown University
Eric Gartman
Brown University
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”